Health-related quality of life in long-term survivors after high-dose chemoradiotherapy followed by surgery in esophageal cancer

Diseases of the Esophagus

Volumn 24, Issue 1, 2011, Pages 39-47

  Hurmuzlu, M ^a,b   Aarstad, H J ^b,c   Aarstad, A K H ^c,e   Hjermstad, M J ^f,g   Viste, A ^b,d  

^a Section for Rheumatology   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c Head and Neck Surgery   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e BERGEN UNIVERSITY COLLEGE   (Norway)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Combined modality therapy; Esophageal neoplasms; Esophagectomy; Quality of life; Radiotherapy dosage

Indexed keywords

CISPLATIN; FLUOROURACIL;

ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PAIN; CANCER SURGERY; CANCER SURVIVOR; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG MEGADOSE; DYSPHAGIA; ESOPHAGEAL CANCER MODULE; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER; FATIGUE; FEMALE; FUNCTIONAL STATUS; HEAD AND NECK CANCER; HUMAN; INSOMNIA; LARYNGECTOMY; MALE; MULTIMODALITY CANCER THERAPY; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; THORAX PAIN; VOMITING;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DOSE FRACTIONATION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FATIGUE; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGECTOMY; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NORWAY; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY, ADJUVANT; SARCOMA; STATISTICS, NONPARAMETRIC; SURVIVORS;

EID: 79551603586     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2010.01104.x     Document Type: Article

References (34)

1. Reynolds J V, McLaughlin R, Moore J, Rowley S, Ravi N, Byrne P J. Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. Br J Surg 2006; 93 (9): 1084-90.
2. Blazeby J M, Sanford E, Falk S J, Alderson D, Donovan J L. Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma. Cancer 2005; 103 (9): 1791-9.
3. van Meerten E, van der Gaast A, Looman C W, Tilanus H W, Muller K, Essink-Bot M L. Quality of life during neoadjuvant treatment and after surgery for resectable esophageal carcinoma. Int J Radiat Oncol Biol Phys 2008; 71 (1): 160-6.
4. Aaronson N K, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85 (5): 365-76.
5. Blazeby J M, Alderson D, Winstone K et al. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. Eur J Cancer 1996; 32A (11): 1912-7.
6. Blazeby J M, Conroy T, Hammerlid E et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 2003; 39 (10): 1384-94.
7. Bjordal K, Hammerlid E, Ahlner-Elmqvist M et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 1999; 17 (3): 1008-19.
8. Fayers P, Aaronson N K, Bjordal K, Groenvold M, Curran D, Bottomley A on behalf of the EORTC Quality of Life Group. The EORTC QLQ-C30 Scoring Manual, 3rd edn. Brussels: European Organisation for Research and Treatment of Cancer, 2001.
9. Sobin L H, Wittekind C. International Union Against Cancer. TNM: Classification of Malignant Tumours, 6th edn. New York: Wiley-Liss, 2002.
10. Hurmuzlu M, Ovrebo K K, Monge O R, Smaaland R, Wentzel-Larsen T, Viste A. High-dose chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer: a retrospective cohort study. World J Surg Oncol 2010; 8 (1): 46.
11. Aarstad H J, Aarstad A K, Lybak S, Monge O, Haugen D F, Olofsson J. The amount of treatment versus quality of life in patients formerly treated for head and neck squamous cell carcinomas. Eur Arch Otorhinolaryngol 2006; 263 (1): 9-15.
12. Birkhaug E J, Aarstad H J, Aarstad A K, Olofsson J. Relation between mood, social support and the quality of life in patients with laryngectomies. Eur Arch Otorhinolaryngol 2002; 259 (4): 197-204.
13. Hjermstad M J, Fayers P M, Bjordal K, Kaasa S. Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+3). J Clin Oncol 1998; 16 (3): 1188-96.
14. Hjermstad M J, Fayers P M, Bjordal K, Kaasa S. Using reference data on quality of life - the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). Eur J Cancer 1998; 34 (9): 1381-9.
15. Djarv T, Lagergren J, Blazeby J M, Lagergren P. Long-term health-related quality of life following surgery for oesophageal cancer. Br J Surg 2008; 95 (9): 1121-6.
16. De Boer A G, Genovesi P I, Sprangers M A, Van Sandick J W, Obertop H, Van Lanschot J J. Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma. Br J Surg 2000; 87 (12): 1716-21.
17. Hurmuzlu M, Monge O R, Smaaland R, Viste A. High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advanced esophageal cancer: toxicity and outcome. Dis Esophagus 2009; 23: 244-52.
18. Pijls-Johannesma M, Houben R, Boersma L et al. High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL. Radiother Oncol 2009; 91 (3): 443-8.
19. Woo B, Dibble S L, Piper B F, Keating S B, Weiss M C. Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum 1998; 25 (5): 915-20.
20. Djarv T, Blazeby J M, Lagergren P. Predictors of postoperative quality of life after esophagectomy for cancer. J Clin Oncol 2009; 27 (12): 1963-8.
21. Aarstad A K, Aarstad H J, Olofsson J. Personality and choice of coping predict quality of life in head and neck cancer patients during follow-up. Acta Oncol 2008; 47 (5): 879-90.
22. Aarstad H J, Aarstad A K, Birkhaug E J, Bru E, Olofsson J. The personality and quality of life in HNSCC patients following treatment. Eur J Cancer 2003; 39 (13): 1852-60.
23. de Boer A G, van Lanschot J J, van Sandick J W et al. Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 2004; 22 (20): 4202-8.
24. Apolone G, Filiberti A, Cifani S, Ruggiata R, Mosconi P. Evaluation of the EORTC QLQ-C30 questionnaire: a comparison with SF-36 Health Survey in a cohort of Italian long-survival cancer patients. Ann Oncol 1998; 9 (5): 549-57.
25. Loge J H, Abrahamsen A F, Ekeberg O, Kaasa S. Hodgkin's disease survivors more fatigued than the general population. J Clin Oncol 1999; 17 (1): 253-61.
26. Bower J E, Ganz P A, Desmond K A, Rowland J H, Meyerowitz B E, Belin T R. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 2000; 18 (4): 743-53.
27. Miaskowski C, Lee K A. Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J Pain Symptom Manage 1999; 17 (5): 320-32.
28. Winningham M L, Nail L M, Burke M B et al. Fatigue and the cancer experience: the state of the knowledge. Oncol Nurs Forum 1994; 21 (1): 23-36.
29. Broeckel J A, Jacobsen P B, Horton J, Balducci L, Lyman G H. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 1998; 16 (5): 1689-96.
30. Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 2002; 38 (1): 27-43.
31. Roscoe J A, Morrow G R, Hickok J T et al. Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer 2002; 10 (4): 329-36.
32. Jacobsen P B, Andrykowski M A, Thors C L. Relationship of catastrophizing to fatigue among women receiving treatment for breast cancer. J Consult Clin Psychol 2004; 72 (2): 355-61.
33. Stone P, Richards M, A'Hern R, Hardy J. Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. J Pain Symptom Manage 2001; 22 (6): 1007-15.
34. Minsky B D, Pajak T F, Ginsberg R J et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002; 20 (5): 1167-74.